España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Regulus Therapeutics
RGLS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.59
0.04
2.58%
At close: -
$1.59
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
Regulus Therapeutics (RGLS) Forecast
News
Earnings
Regulus Therapeutics (RGLS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Regulus Therapeutics (NASDAQ:RGLS) Stock
Regulus Therapeutics Stock (NASDAQ: RGLS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Thursday, November 07, 2024
Regulus Therapeutics Q3 EPS $(0.21) Misses $(...
Benzinga Newsdesk
Wednesday, October 30, 2024
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Monday, October 28, 2024
Watching Regulus Therapeutics, Ventyx Bioscie...
Benzinga Newsdesk
Tuesday, October 08, 2024
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Regulus Therapeutics Completes Enrollment Of ...
Benzinga Newsdesk
Wednesday, August 14, 2024
Oppenheimer Reiterates Outperform on Regulus ...
Benzinga Newsdesk
Friday, August 09, 2024
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Thursday, August 08, 2024
Regulus Therapeutics Q2 EPS $(0.17) Misses $(...
Benzinga Newsdesk
Tuesday, July 16, 2024
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Tuesday, June 25, 2024
Canaccord Genuity Maintains Buy on Regulus Th...
Benzinga Newsdesk
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Regulus ...
Benzinga Newsdesk
Monday, June 24, 2024
What's Going On With Regulus Therapeutics Stock Monday?
Dylan Berman
Regulus Therapeutics shares are trading lower...
Benzinga Newsdesk
Market-Moving News for June 24th
Benzinga Newsdesk
Regulus Therapeutics shares are trading highe...
Benzinga Newsdesk
Regulus Therapeutics Announces Results in Pha...
Benzinga Newsdesk
Tuesday, June 04, 2024
Regulus Therapeutics Announces Expected Addit...
Benzinga Newsdesk
Friday, May 31, 2024
Jones Trading Initiates Coverage On Regulus T...
Benzinga Newsdesk
Wednesday, May 22, 2024
Bio-Techne And Regulus Therapeutics Announced...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Thursday, May 09, 2024
Regulus Therapeutics Q1 2024 GAAP EPS $(0.29)...
Benzinga Newsdesk
Monday, May 06, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Regulus Therapeutics Advances To Cohort 4 Of ...
Benzinga Newsdesk
Monday, March 25, 2024
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Thursday, March 21, 2024
Regulus Therapeutics Q4 EPS $(0.40) Misses $(0.39) Estimate
Happy Mohamed
Tuesday, March 19, 2024
Canaccord Genuity Maintains Buy on Regulus Th...
Benzinga Newsdesk
Monday, March 18, 2024
Leerink Partners Initiates Coverage On Regulu...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk
Thursday, March 14, 2024
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Wednesday, March 13, 2024
Regulus Therapeutics shares are trading highe...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Regulus...
Benzinga Newsdesk
Tuesday, March 12, 2024
Gold Down Over 1%; ClearOne Shares Spike Higher
Avi Kapoor
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
Avi Kapoor
Regulus Therapeutics Shares Resume Trade
Benzinga Newsdesk
Regulus Therapeutics Shares Halted On Circuit...
Benzinga Newsdesk
Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Market-Moving News for March 12th
Benzinga Newsdesk
Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday?
Vandana Singh
Regulus Therapeutics shares are trading highe...
Benzinga Newsdesk
Regulus Therapeutics Announces Oversubscribed...
Benzinga Newsdesk
Regulus Therapeutics Released Topline Data Fr...
Benzinga Newsdesk
Tuesday, January 02, 2024
Regulus Therapeutics Completes Enrollment In ...
Benzinga Newsdesk
Thursday, November 02, 2023
Regulus Therapeutics Announced The Dosing Of ...
Benzinga Newsdesk
Thursday, October 19, 2023
Regulus Therapeutics Will Advance To Third Co...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch